Equities analysts expect Inspire Medical Systems (NYSE:INSP) to report ($0.44) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Inspire Medical Systems’ earnings. The highest EPS estimate is ($0.37) and the lowest is ($0.55). Inspire Medical Systems reported earnings of ($0.22) per share in the same quarter last year, which indicates a negative year over year growth rate of 100%. The firm is expected to announce its next earnings report on Tuesday, February 25th.
On average, analysts expect that Inspire Medical Systems will report full year earnings of ($1.46) per share for the current financial year, with EPS estimates ranging from ($1.56) to ($1.39). For the next year, analysts expect that the company will report earnings of ($1.54) per share, with EPS estimates ranging from ($1.83) to ($1.04). Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover Inspire Medical Systems.
Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Tuesday, November 5th. The company reported ($0.34) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.43) by $0.09. The company had revenue of $20.86 million for the quarter, compared to the consensus estimate of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. Inspire Medical Systems’s revenue was up 59.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.22) earnings per share.
NYSE:INSP traded down $0.13 during trading hours on Monday, reaching $70.83. 191,100 shares of the company were exchanged, compared to its average volume of 298,940. The company has a debt-to-equity ratio of 0.17, a current ratio of 13.42 and a quick ratio of 13.05. The firm has a market cap of $1.71 billion, a price-to-earnings ratio of -47.22 and a beta of 1.27. Inspire Medical Systems has a 52-week low of $35.43 and a 52-week high of $72.31. The stock has a 50 day simple moving average of $60.90 and a 200 day simple moving average of $61.66.
In other news, insider Randy Ban sold 10,000 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $61.62, for a total value of $616,200.00. Also, Director Orbimed Advisors Llc sold 53,387 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $71.63, for a total transaction of $3,824,110.81. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 229,577 shares of company stock worth $15,219,882. 12.10% of the stock is currently owned by insiders.
Several institutional investors have recently added to or reduced their stakes in the company. Man Group plc acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $5,739,000. Partner Investment Management L.P. acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $217,000. Redmile Group LLC acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $239,000. California State Teachers Retirement System increased its position in shares of Inspire Medical Systems by 1.8% in the third quarter. California State Teachers Retirement System now owns 20,887 shares of the company’s stock worth $1,275,000 after acquiring an additional 377 shares in the last quarter. Finally, Stifel Financial Corp grew its holdings in Inspire Medical Systems by 22.4% during the 3rd quarter. Stifel Financial Corp now owns 7,637 shares of the company’s stock valued at $467,000 after purchasing an additional 1,398 shares in the last quarter. 89.74% of the stock is owned by institutional investors.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Recommended Story: How to Invest in Growth Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.